Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Medtronic
Mallinckrodt
Queensland Health
Accenture
Johnson and Johnson
Covington
QuintilesIMS
Moodys

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065155

« Back to Dashboard

NDA 065155 describes CLARITHROMYCIN, which is a drug marketed by Sandoz, Sun Pharm Inds Ltd, Actavis Labs Fl Inc, Allied Pharma Inc, Idt Australia Ltd, Lupin Ltd, Mayne Pharma, Ranbaxy, Apotex Corp, Aurobindo, Hec Pharm Usa Inc, Ivax Sub Teva Pharms, Mylan, Teva, West-ward Pharms Int, and Wockhardt, and is included in twenty NDAs. It is available from twenty-five suppliers. Additional details are available on the CLARITHROMYCIN profile page.

The generic ingredient in CLARITHROMYCIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
Summary for 065155
Tradename:CLARITHROMYCIN
Applicant:Teva
Ingredient:clarithromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 065155
Suppliers and Packaging for NDA: 065155
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITHROMYCIN clarithromycin TABLET;ORAL 065155 ANDA Teva Pharmaceuticals USA Inc 0093-7528 N 0093-7528-06
CLARITHROMYCIN clarithromycin TABLET;ORAL 065155 ANDA Teva Pharmaceuticals USA Inc 0093-7529 N 0093-7529-06

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:May 31, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:May 31, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Covington
Dow
Mallinckrodt
QuintilesIMS
McKesson
Medtronic
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.